Completed PHASE2 INTERVENTIONAL 4-arm NCT00985439

Study of Diclofenac Capsules to Treat Dental Pain

A Phase 2, Randomized, Double-Blind, Single-Dose, Parallel-Group, Active- and Placebo-Controlled Study of Diclofenac [Test] Capsules for the Treatment of Pain After Surgical Removal of Impacted Third Molars

Sponsor: Iroko Pharmaceuticals, LLC

Conditions Dental Pain

Interventions Celecoxib 400 mg Diclofenac Test (lower dose) Diclofenac Test (upper dose) Placebo

Updated 6 times since 2017 Last updated: May 15, 2012 Started: Sep 30, 2009 Primary completion: Dec 31, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00985439, this PHASE2 trial focuses on Dental Pain and remains completed. Sponsored by Iroko Pharmaceuticals, LLC, it has been updated 6 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Sep 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Iroko Pharmaceuticals, LLC

Data source: Iroko Pharmaceuticals, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Austin, United States